名词解释 新辅助化疗: 也称为诱导化疗(induction chemotherapy)或术前化疗(preoperative chemotherapy), 是希望通过术前化疗缩小肿瘤以提高完全切除率, 同时通过减少微转移灶而提高长期生存率的化疗方法.
基于196个网页-相关网页
preoperative chemotherapy time 术前化疗时间
short course preoperative chemotherapy 术前短程化疗
preoperative regional intra-arterial chemotherapy 区域动脉灌注化疗 ; 术前区域动脉灌注化疗
preoperative arterial infusion chemotherapy 术前动脉介入化疗 ; 术前动脉灌注化疗
preoperative arterial chemotherapy 术前动脉化疗
preoperative induced chemotherapy 诱导化疗
Conclusion The major factors influencing preoperative chemotherapy response were tumor volume,post-chemotherapy AKP,the lowest level of post-chemotherapy peripheral blood leucocytes and chemotherapy protocol.
结论肿瘤体积、化疗后AKP、化疗后白细胞最低值和化疗方案是影响骨肉瘤术前化疗疗效的最主要因素。
参考来源 - 影响ⅡB期骨肉瘤术前化疗疗效的多因素分析·2,447,543篇论文数据，部分数据来源于NoteExpress
Objective To assess the effect of preoperative chemotherapy on invasive thymoma.
目的评价术前化疗在进展期恶性胸腺瘤治疗中的作用。
This article reviewed the development of preoperative chemotherapy in colorectal cancer and liver metastasis.
本文仅对目前结直肠癌及肝转移的术前辅助化疗进展做一综述。
CONCLUSIONS: Preoperative chemotherapy is not associated with an increase in either the mortality rate or major surgical complications.
结论：术前化疗不未增加死亡率或主要的手术并发症。
应用推荐